Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: DPYS[original query] |
---|
Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism. Pharmacogenetics and genomics 2007 Nov 17 (11): 973-87. Thomas Holly R, Ezzeldin Hany H, Guarcello Vincenzo, Mattison Lori K, Fridley Brooke L, Diasio Robert |
Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Pharmacogenetics and genomics 2008 Jan 18 (1): 25-35. Thomas Holly R, Ezzeldin Hany H, Guarcello Vincenzo, Mattison Lori K, Fridley Brooke L, Diasio Robert |
Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients. Cancer chemotherapy and pharmacology 2010 Mar 65 (4): 661-9. Fidlerova Julie, Kleiblova Petra, Bilek Matej, Kormunda Stanislav, Formankova Zuzana, Novotny Jan, Kleibl Zden |
Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT. BMB reports 2010 Aug 43 (8): 547-53. Kim Hyo Young, Cho Seoae, Yu Jeongmi, Sung Samsun, Kim Heeb |
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity. British journal of cancer 2013 Jun 108 (12): 2505-15. Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis C M, Harper P, Maisey N, Ross P, Sanderson J D, Marinaki A |
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular nutrition & food research 2014 Oct 58 (10): 2023-35. Kelemen Linda E, Terry Kathryn L, Goodman Marc T, Webb Penelope M, Bandera Elisa V, McGuire Valerie, Rossing Mary Anne, Wang Qinggang, Dicks Ed, Tyrer Jonathan P, Song Honglin, Kupryjanczyk Jolanta, Dansonka-Mieszkowska Agnieszka, Plisiecka-Halasa Joanna, Timorek Agnieszka, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, Ramus Susan J, Narod Steven A, Risch Harvey A, McLaughlin John R, Siddiqui Nadeem, Glasspool Rosalind, Paul James, Carty Karen, Gronwald Jacek, Lubi?ski Jan, Jakubowska Anna, Cybulski Cezary, Kiemeney Lambertus A, Massuger Leon F A G, van Altena Anne M, Aben Katja K H, Olson Sara H, Orlow Irene, Cramer Daniel W, Levine Douglas A, Bisogna Maria, Giles Graham G, Southey Melissa C, Bruinsma Fiona, Kjaer Susanne K, Høgdall Estrid, Jensen Allan, Høgdall Claus K, Lundvall Lene, Engelholm Svend-Aage, Heitz Florian, du Bois Andreas, Harter Philipp, Schwaab Ira, Butzow Ralf, Nevanlinna Heli, Pelttari Liisa M, Leminen Arto, Thompson Pamela J, Lurie Galina, Wilkens Lynne R, Lambrechts Diether, Van Nieuwenhuysen Els, Lambrechts Sandrina, Vergote Ignace, Beesley Jonathan, , Fasching Peter A, Beckmann Matthias W, Hein Alexander, Ekici Arif B, Doherty Jennifer A, Wu Anna H, Pearce Celeste L, Pike Malcolm C, Stram Daniel, Chang-Claude Jenny, Rudolph Anja, Dörk Thilo, Dürst Matthias, Hillemanns Peter, Runnebaum Ingo B, Bogdanova Natalia, Antonenkova Natalia, Odunsi Kunle, Edwards Robert P, Kelley Joseph L, Modugno Francesmary, Ness Roberta B, Karlan Beth Y, Walsh Christine, Lester Jenny, Orsulic Sandra, Fridley Brooke L, Vierkant Robert A, Cunningham Julie M, Wu Xifeng, Lu Karen, Liang Dong, Hildebrandt Michelle A T, Weber Rachel Palmieri, Iversen Edwin S, Tworoger Shelley S, Poole Elizabeth M, Salvesen Helga B, Krakstad Camilla, Bjorge Line, Tangen Ingvild L, Pejovic Tanja, Bean Yukie, Kellar Melissa, Wentzensen Nicolas, Brinton Louise A, Lissowska Jolanta, Garcia-Closas Montserrat, Campbell Ian G, Eccles Diana, Whittemore Alice S, Sieh Weiva, Rothstein Joseph H, Anton-Culver Hoda, Ziogas Argyrios, Phelan Catherine M, Moysich Kirsten B, Goode Ellen L, Schildkraut Joellen M, Berchuck Andrew, Pharoah Paul D P, Sellers Thomas A, Brooks-Wilson Angela, Cook Linda S, Le Nhu |
Dihydropyrimidinase and ß-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. Pharmacogenomics 2015 Aug 16 (12): 1367-77. Kummer Dominic, Froehlich Tanja K, Joerger Markus, Aebi Stefan, Sistonen Johanna, Amstutz Ursula, Largiadèr Carlo |
Novel single nucleotide polymorphisms of the dihydropyrimidinase gene (DPYS) in Japanese individuals. Drug metabolism and pharmacokinetics 2015 Feb 30 (1): 127-9. Akai Fumika, Hosono Hiroki, Hirasawa Noriyasu, Hiratsuka Masahi |
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach. Metabolomics : open access 2016 Aug 12 . de Oliveira Felipe A, Shahin Mohamed H, Gong Yan, McDonough Caitrin W, Beitelshees Amber L, Gums John G, Chapman Arlene B, Boerwinkle Eric, Turner Stephen T, Frye Reginald F, Fiehn Oliver, Kaddurah-Daouk Rima, Johnson Julie A, Cooper-DeHoff Rhonda |
Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients. Therapeutic drug monitoring 2018 May . Duley John A, Ni Ming, Shannon Catherine, Norris Ross L, Sheffield Leslie, Cowley David, Harris Marion, van Kuilenburg André B P, Helsby Nuala, George Rani, Charles Bruce |
Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer. Cancer science 2020 Jul . Yokoi Katsuyuki, Nakajima Yoko, Matsuoka Hiroshi, Shinkai Yasuko, Ishihara Takuma, Maeda Yasuhiro, Kato Takema, Katsuno Hidetoshi, Masumori Koji, Kawada Kenji, Yoshikawa Tetsushi, Ito Tetsuya, Kurahashi Hiro |
Genome-wide scan identifies novel genetic loci regulating salivary metabolite levels.
Human molecular genetics 2020 Mar 29 (5): 864-875. Nag Abhishek, Kurushima Yuko, Bowyer Ruth C E, Wells Philippa M, Weiss Stefan, Pietzner Maik, Kocher Thomas, Raffler Johannes, Völker Uwe, Mangino Massimo, Spector Timothy D, Milburn Michael V, Kastenmüller Gabi, Mohney Robert P, Suhre Karsten, Menni Cristina, Steves Claire |
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine. Cancer chemotherapy and pharmacology 2021 Feb . Liu Duo, Li Xuehua, Li Xiang, Wang Huiqi, Dong M |
Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity. Drug metabolism and disposition: the biological fate of chemicals 2022 11 51 (2): 165-173. Hishinuma Eiji, Narita Yoko, Rico Evelyn Marie Gutiérrez, Ueda Akiko, Obuchi Kai, Tanaka Yoshikazu, Saito Sakae, Tadaka Shu, Kinoshita Kengo, Maekawa Masamitsu, Mano Nariyasu, Nakayoshi Tomoki, Oda Akifumi, Hirasawa Noriyasu, Hiratsuka Masahi |
Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort. Pharmacogenetics and genomics 2024 1 . Samantha J Medwid, Jaymie L Mailloux, Theodore J Wigle, Richard B K |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: